Comparison of exhaled endogenous particles from smokers and non-smokers using multivariate analysis

Respiration

Volumn 86, Issue 2, 2013, Pages 135-142

  Bredberg, Anna ^a   Josefson, Mats ^b   Almstrand, Ann Charlotte ^a   Lausmaa, Jukka ^c   Sjövall, Peter ^c   Levinsson, Anna ^a   Larsson, Per ^a   Olin, Anna Carin ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c SP TECHNICAL RESEARCH INSTITUTE OF SWEDEN   (Sweden)

Author keywords

Cigarette smoking; Inflammation; Orthogonal partial least squares; Particles in exhaled air; Phospholipids; Respiratory tract lining fluid; Time of flight secondary ion mass spectrometry

Indexed keywords

NITRIC OXIDE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ADULT; AGED; ARTICLE; CHEMICAL COMPOSITION; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; MASS SPECTROMETRY; MATERIAL STATE; MULTIVARIATE ANALYSIS; PARTIAL LEAST SQUARES REGRESSION; PARTICLES IN EXHALED AIR; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SMOKING; SPIROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; AIR; BREATH TESTS; EXHALATION; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITRIC OXIDE; SMOKING;

EID: 84883177078     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000350941     Document Type: Article

References (31)

1. Maestrelli P, Saetta M, Mapp CE, Fabbri LM: Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 76-80.
2. Adcock IM, Caramori G, Barnes PJ: Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 2011; 81: 265-284.
3. Goerke J: Lung surfactant. Biochim Biophys Acta 1974; 344: 241-261.
4. Heeley EL, Hohlfeld JM, Krug N, Postle AD: Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma. Am J Physiol Lung Cell Mol Physiol 2000; 278:L305-L311.
5. Mander A, Langton-Hewer S, Bernhard W, Warner JO, Postle AD: Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections. Am J Respir Cell Mol Biol 2002; 27: 714-721.
6. Wright SM, Hockey PM, Enhorning G, Strong P, Reid KB, Holgate ST, et al: Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol 2000; 89: 1283-1292.
7. Isajevs S, Taivans I, Svirina D, Strazda G, Kopeika U: Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease. Respiration 2011; 81: 362-371.
8. Hughes DA, Haslam PL: Effect of smoking on the lipid composition of lung lining fluid and relationship between immunostimulatory lipids, inflammatory cells and foamy macrophages in extrinsic allergic alveolitis. Eur Respir J 1990; 3: 1128-1139.
9. Plymoth A, Lfdahl CG, Ekberg-Jansson A, Dahlback M, Broberg P, Foster M, et al: Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers. Clin Chem 2007; 53: 636-644.
10. More J, Voelker D, Silveira L, Edwards M, Chan E, Bowler R: Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med 2010; 10: 53.
11. Almstrand A-C, Ljungstrm E, Lausmaa J, Bake B, Sjvall P, Olin A-C: Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Anal Chem 2008; 81: 662-668.
12. Almstrand AC, Bake B, Ljungstrm E, Larsson P, Bredberg A, Mirgorodskaya E, et al: Effect of airway opening on production of exhaled particles. J Appl Physiol 2010; 108: 584-588.
13. Bredberg A, Gobom J, Almstrand AC, Larsson P, Blennow K, Olin AC, et al: Exhaled endogenous particles contain lung proteins. Clin Chem 2012; 58: 431-440.
14. Benninghoven A: Surface analysis by Secondary Ion Mass Spectrometry (SIMS). Surf Sci 1994; 299/300: 246-260.
15. Saleem M, Galla H-J: Surface view of the lateral organization of lipids and proteins in lung surfactant model systems - a ToF-SIMS approach. Biochim Biophys Acta 2010; 1798: 730-740.
16. Graham DJ, Wagner MS, Castner DG: Information from complexity: challenges of TOFSIMS data interpretation. Appl Surf Sci 2006; 252: 6860-6868.
17. Berman ESF, Wu L, Fortson SL, Kulp KS, Nelson DO, Wu KJ: Chemometric and statistical analyses of ToF-SIMS spectra of increasingly complex biological samples. Surf Interface Anal 2009; 41: 97-104.
18. Tyler BJ, Rayal G, Castner DG: Multivariate analysis strategies for processing ToF-SIMS images of biomaterials. Biomaterials 2007; 28: 2412-2423.
19. Wagner MS, Graham DJ, Castner DG: Simplifying the interpretation of ToF-SIMS spectra and images using careful application of multivariate analysis. Appl Surf Sci 2006; 252: 6575-6581.
20. Trygg J, Wold S: Orthogonal projections to latent structures (O-PLS). J Chemom 2002; 16: 119-128.
21. American Thoracic Society, European Respiratory Society: ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
23. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
24. Trygg J, Holmes E, Lundstedt T: Chemometrics in metabonomics. J Proteome Res 2006; 6: 469-479.
25. van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ: Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006; 7: 142.
26. Bylesj M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J: OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom 2006; 20: 341-351.
27. Wiklund S, Johansson E, Sjstrom L, Mellerowicz EJ, Edlund U, Shockcor JP, et al: Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 2008; 80: 115-122.
28. Almstrand A-C, Josefson M, Bredberg A, Lausmaa J, Sjvall P, Larsson P, et al: TOFSIMS analysis of exhaled particles from patients with asthma and healthy controls. Eur Respir J 2012; 39: 59-66.
29. Belu AM, Graham DJ, Castner DG: Time-offlight secondary ion mass spectrometry: techniques and applications for the characterization of biomaterial surfaces. Biomaterials 2003; 24: 3635-3653.
30. Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, Loo JA, et al: Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 2005; 5: 1714-1728.
31. Seasholtz MB, Kowalski BR: Qualitative information from multivariate calibration models. Appl Spectrosc 1990; 44: 1337-1348.